Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Hepatology (Baltimore, Md.)
|
January 13, 1998
Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
M Guevara, P Ginès, G Fernández-Esparrach, et al.
Hepatology (Baltimore, Md.)
|
July 10, 1998
Increased cerebrovascular resistance in cirrhotic patients with ascites
M Guevara, C Bru, P Ginès, et al.
Journal of Hepatology
|
February 12, 1998
Urinary endothelin-like immunoreactivity in patients with cirrhosis
J Saló, G Fernández-Esparrach, P Ginès, et al.
Hepatology (Baltimore, Md.)
|
August 26, 1999
Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients
W Jiménez, J Ros, M Morales-Ruiz, et al.
Journal of Hepatology
|
November 19, 1997
Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis
J Saló, A Ginès, P Ginès, et al.
Endoscopy
|
October 1, 1995
Duodenal variceal bleeding treated with a transjugular intrahepatic portosystemic shunt
P Sort, I Elizalde, I Llach, et al.
Journal of Hepatology
|
July 25, 2000
Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome
J Uriz, P Ginès, A Cárdenas, et al.
Gastroenterology
|
February 7, 1998
Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems
M Guevara, P Ginès, W Jiménez, et al.
Hepatology (Baltimore, Md.)
|
August 8, 1998
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems
M Guevara, P Ginès, J C Bandi, et al.
Journal of Hepatology
|
March 1, 1997
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo
G Fernández-Esparrach, M Guevara, P Sort, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Hepatology (Baltimore, Md.)
|
January 13, 1998
Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
M Guevara, P Ginès, G Fernández-Esparrach, et al.
Hepatology (Baltimore, Md.)
|
July 10, 1998
Increased cerebrovascular resistance in cirrhotic patients with ascites
M Guevara, C Bru, P Ginès, et al.
Journal of Hepatology
|
February 12, 1998
Urinary endothelin-like immunoreactivity in patients with cirrhosis
J Saló, G Fernández-Esparrach, P Ginès, et al.
Hepatology (Baltimore, Md.)
|
August 26, 1999
Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients
W Jiménez, J Ros, M Morales-Ruiz, et al.
Journal of Hepatology
|
November 19, 1997
Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis
J Saló, A Ginès, P Ginès, et al.
Endoscopy
|
October 1, 1995
Duodenal variceal bleeding treated with a transjugular intrahepatic portosystemic shunt
P Sort, I Elizalde, I Llach, et al.
Journal of Hepatology
|
July 25, 2000
Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome
J Uriz, P Ginès, A Cárdenas, et al.
Gastroenterology
|
February 7, 1998
Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems
M Guevara, P Ginès, W Jiménez, et al.
Hepatology (Baltimore, Md.)
|
August 8, 1998
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems
M Guevara, P Ginès, J C Bandi, et al.
Journal of Hepatology
|
March 1, 1997
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo
G Fernández-Esparrach, M Guevara, P Sort, et al.
Page
of 3